Mehtap Yeni

Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Detection of Hypokalemia, Hyponatremia, and Hyperkalemia in Heart Failure Patients Using Artificial Intelligence Techniques via Electrocardiography.

Detection of Hypokalemia, Hyponatremia, and Hyperkalemia in Heart Failure Patients Using Artificial Intelligence Techniques via Electrocardiography.

Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

Published: October 09, 2025

Clinical Profiles and In-Hospital Outcomes of Pre-Existing Versus Newly Diagnosed Atrial Fibrillation in Coronary Care Units: Insights From the MORCOR-TURK National Registry.

Clinical Profiles and In-Hospital Outcomes of Pre-Existing Versus Newly Diagnosed Atrial Fibrillation in Coronary Care Units: Insights From the MORCOR-TURK National Registry.

Journal: Journal of arrhythmia

Published: August 31, 2025

Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.

Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.

Journal: ESC heart failure

Published: June 22, 2023

Rationale, Design, and Methodology of the MORCOR-TURK Trial: Predictors of In-hospital MORtality in CORonary Care Patients in Turkey.

Rationale, Design, and Methodology of the MORCOR-TURK Trial: Predictors of In-hospital MORtality in CORonary Care Patients in Turkey.

Journal: Anatolian journal of cardiology

Published: April 29, 2023

COVID-19 BNT162b2 mRNA vaccine induced myocarditis with left ventricular thrombus in a young male.

COVID-19 BNT162b2 mRNA vaccine induced myocarditis with left ventricular thrombus in a young male.

Journal: Acta cardiologica

Published: January 23, 2023

The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study).

The Safety and Tolerability of Nebivolol in Hypertensive Patients with Coronary Artery Disease and Left Ventricular Ejection Fraction ≥ 40%: A Population-Based Cohort Study (Nebivolol-TR Study).

Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

Published: November 01, 2022

Comparison of long-term outcome of patients with ST-segment elevation myocardial infarction between pre-COVID-19 and COVID-19 era.

Comparison of long-term outcome of patients with ST-segment elevation myocardial infarction between pre-COVID-19 and COVID-19 era.

Journal: European journal of clinical investigation

Published: May 31, 2022

Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry).

Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry).

Journal: Journal of thrombosis and thrombolysis

Published: May 18, 2021

Gender-related clinical and management differences in patients with chronic heart failure with reduced ejection fraction.

Gender-related clinical and management differences in patients with chronic heart failure with reduced ejection fraction.

Journal: International journal of clinical practice

Published: July 30, 2020

Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study.

Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study.

Journal: Anatolian journal of cardiology

Published: July 07, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026